Development, Current Status, and Remaining Challenges for Respiratory Syncytial Virus Vaccines
Respiratory syncytial virus (RSV) causes significant morbidity and mortality, especially in young children and the elderly. RSV vaccine development puzzled vaccinologists for years. Safety concerns of initial formulations, the lack of an absolute correlate of protection, and the need for selecting a...
Zapisane w:
| Główni autorzy: | , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
MDPI AG
2025-01-01
|
| Seria: | Vaccines |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.mdpi.com/2076-393X/13/2/97 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|